Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond

Remco de Bree, Gregory T. Wolf, Bart de Keizer, Iain J. Nixon, Dana M. Hartl, Arlene A. Forastiere, Missak Haigentz, Alessandra Rinaldo, Juan P. Rodrigo, Nabil F. Saba, Carlos Suárez, Jan B. Vermorken, Alfio Ferlito

Research output: Contribution to journalReview article

Abstract

Significant correlations between the response to induction chemotherapy and success of subsequent radiotherapy have been reported and suggest that the response to induction chemotherapy is able to predict a response to radiotherapy. Therefore, induction chemotherapy may be used to tailor the treatment plan to the individual patient with head and neck cancer: following the planned subsequent (chemo)radiation schedule, planning a radiation dose boost, or reassessing the modality of treatment (eg, upfront surgery). Findings from reported trials suggest room for improvement in clinical response assessment after induction chemotherapy, but an optimal method has yet to be identified. Historically, indices of treatment efficacy in solid tumors have been based solely on systematic assessment of tumor size. However, functional imaging (eg, fluorodeoxyglucose-positron emission tomography (FDG-PET) potentially provides an earlier indication of response to treatment than conventional imaging techniques. More advanced imaging techniques are still in an exploratory phase and are not ready for use in clinical practice.

Original languageEnglish (US)
Pages (from-to)2329-2349
Number of pages21
JournalHead and Neck
Volume39
Issue number11
DOIs
StatePublished - Nov 1 2017

Fingerprint

Induction Chemotherapy
Physical Examination
Radiotherapy
Radiation
Head and Neck Neoplasms
Positron-Emission Tomography
Neoplasms
Appointments and Schedules
Therapeutics
Carcinoma, squamous cell of head and neck

Keywords

  • fluorodeoxyglucose-positron emission tomography (FDG-PET)
  • head and neck squamous cell carcinoma
  • induction chemotherapy
  • response assessment

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma : From physical examination to modern imaging techniques and beyond. / de Bree, Remco; Wolf, Gregory T.; de Keizer, Bart; Nixon, Iain J.; Hartl, Dana M.; Forastiere, Arlene A.; Haigentz, Missak; Rinaldo, Alessandra; Rodrigo, Juan P.; Saba, Nabil F.; Suárez, Carlos; Vermorken, Jan B.; Ferlito, Alfio.

In: Head and Neck, Vol. 39, No. 11, 01.11.2017, p. 2329-2349.

Research output: Contribution to journalReview article

de Bree, R, Wolf, GT, de Keizer, B, Nixon, IJ, Hartl, DM, Forastiere, AA, Haigentz, M, Rinaldo, A, Rodrigo, JP, Saba, NF, Suárez, C, Vermorken, JB & Ferlito, A 2017, 'Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond', Head and Neck, vol. 39, no. 11, pp. 2329-2349. https://doi.org/10.1002/hed.24883
de Bree, Remco ; Wolf, Gregory T. ; de Keizer, Bart ; Nixon, Iain J. ; Hartl, Dana M. ; Forastiere, Arlene A. ; Haigentz, Missak ; Rinaldo, Alessandra ; Rodrigo, Juan P. ; Saba, Nabil F. ; Suárez, Carlos ; Vermorken, Jan B. ; Ferlito, Alfio. / Response assessment after induction chemotherapy for head and neck squamous cell carcinoma : From physical examination to modern imaging techniques and beyond. In: Head and Neck. 2017 ; Vol. 39, No. 11. pp. 2329-2349.
@article{4d61af9db8e94082a8e25ea45875ee31,
title = "Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond",
abstract = "Significant correlations between the response to induction chemotherapy and success of subsequent radiotherapy have been reported and suggest that the response to induction chemotherapy is able to predict a response to radiotherapy. Therefore, induction chemotherapy may be used to tailor the treatment plan to the individual patient with head and neck cancer: following the planned subsequent (chemo)radiation schedule, planning a radiation dose boost, or reassessing the modality of treatment (eg, upfront surgery). Findings from reported trials suggest room for improvement in clinical response assessment after induction chemotherapy, but an optimal method has yet to be identified. Historically, indices of treatment efficacy in solid tumors have been based solely on systematic assessment of tumor size. However, functional imaging (eg, fluorodeoxyglucose-positron emission tomography (FDG-PET) potentially provides an earlier indication of response to treatment than conventional imaging techniques. More advanced imaging techniques are still in an exploratory phase and are not ready for use in clinical practice.",
keywords = "fluorodeoxyglucose-positron emission tomography (FDG-PET), head and neck squamous cell carcinoma, induction chemotherapy, response assessment",
author = "{de Bree}, Remco and Wolf, {Gregory T.} and {de Keizer}, Bart and Nixon, {Iain J.} and Hartl, {Dana M.} and Forastiere, {Arlene A.} and Missak Haigentz and Alessandra Rinaldo and Rodrigo, {Juan P.} and Saba, {Nabil F.} and Carlos Su{\'a}rez and Vermorken, {Jan B.} and Alfio Ferlito",
year = "2017",
month = "11",
day = "1",
doi = "10.1002/hed.24883",
language = "English (US)",
volume = "39",
pages = "2329--2349",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "11",

}

TY - JOUR

T1 - Response assessment after induction chemotherapy for head and neck squamous cell carcinoma

T2 - From physical examination to modern imaging techniques and beyond

AU - de Bree, Remco

AU - Wolf, Gregory T.

AU - de Keizer, Bart

AU - Nixon, Iain J.

AU - Hartl, Dana M.

AU - Forastiere, Arlene A.

AU - Haigentz, Missak

AU - Rinaldo, Alessandra

AU - Rodrigo, Juan P.

AU - Saba, Nabil F.

AU - Suárez, Carlos

AU - Vermorken, Jan B.

AU - Ferlito, Alfio

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Significant correlations between the response to induction chemotherapy and success of subsequent radiotherapy have been reported and suggest that the response to induction chemotherapy is able to predict a response to radiotherapy. Therefore, induction chemotherapy may be used to tailor the treatment plan to the individual patient with head and neck cancer: following the planned subsequent (chemo)radiation schedule, planning a radiation dose boost, or reassessing the modality of treatment (eg, upfront surgery). Findings from reported trials suggest room for improvement in clinical response assessment after induction chemotherapy, but an optimal method has yet to be identified. Historically, indices of treatment efficacy in solid tumors have been based solely on systematic assessment of tumor size. However, functional imaging (eg, fluorodeoxyglucose-positron emission tomography (FDG-PET) potentially provides an earlier indication of response to treatment than conventional imaging techniques. More advanced imaging techniques are still in an exploratory phase and are not ready for use in clinical practice.

AB - Significant correlations between the response to induction chemotherapy and success of subsequent radiotherapy have been reported and suggest that the response to induction chemotherapy is able to predict a response to radiotherapy. Therefore, induction chemotherapy may be used to tailor the treatment plan to the individual patient with head and neck cancer: following the planned subsequent (chemo)radiation schedule, planning a radiation dose boost, or reassessing the modality of treatment (eg, upfront surgery). Findings from reported trials suggest room for improvement in clinical response assessment after induction chemotherapy, but an optimal method has yet to be identified. Historically, indices of treatment efficacy in solid tumors have been based solely on systematic assessment of tumor size. However, functional imaging (eg, fluorodeoxyglucose-positron emission tomography (FDG-PET) potentially provides an earlier indication of response to treatment than conventional imaging techniques. More advanced imaging techniques are still in an exploratory phase and are not ready for use in clinical practice.

KW - fluorodeoxyglucose-positron emission tomography (FDG-PET)

KW - head and neck squamous cell carcinoma

KW - induction chemotherapy

KW - response assessment

UR - http://www.scopus.com/inward/record.url?scp=85031669104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031669104&partnerID=8YFLogxK

U2 - 10.1002/hed.24883

DO - 10.1002/hed.24883

M3 - Review article

C2 - 28815841

AN - SCOPUS:85031669104

VL - 39

SP - 2329

EP - 2349

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 11

ER -